← Back to Search

Behavioural Intervention

BETTER Program for Traumatic Brain Injury

N/A
Waitlist Available
Led By Tolu O Oyesanya, PhD, Rn
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge

Summary

This trial is looking at a program called BETTER that helps people with traumatic brain injuries (TBI) as they transition from the hospital to home. The program is designed to be culturally-sensitive and focused

Who is the study for?
The BETTER trial is for younger adults aged 18-64 with mild to severe traumatic brain injury (TBI) who are being discharged home from acute hospital care. Participants must be able to follow commands, speak English or Spanish, and have phone access. Primary caregivers of the patients can also join if they're over 18 and meet similar language and phone requirements.
What is being tested?
This study compares a special program called BETTER, which includes education, training, and therapy tailored for TBI patients and their families, against the usual care given after discharge from the hospital. It aims to improve recovery outcomes in racially diverse young adults with TBI.
What are the potential side effects?
Since this trial involves educational and therapeutic interventions rather than medications, traditional side effects are not applicable. However, participants may experience varying levels of stress or emotional discomfort during the recovery process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (24-72 hours pre-discharge); 8-, 16-, and 24-weeks post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in patient SF-36 (36-item Short Form Survey) score
Secondary study objectives
Change in Patient Activation Measure (PAM-10) for patients and caregivers.
Change in caregiver Modified Caregiver Strain Index (MCSI)
Change in caregiver Preparedness for Caregiving Scale
+16 more
Other study objectives
Clinical Factors
Demographics

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BETTER TBI (Traumatic Brain Injury) Transitional Care InterventionExperimental Treatment1 Intervention
Skilled clinical interventionists follow a manualized intervention protocol to address patient/family needs; establish goals; coordinate post-hospital care, services, and resources; and provide patient/family education and training on self- and family-management and coping skills \<16 weeks post-discharge.
Group II: Usual CarePlacebo Group1 Intervention
In alignment with U.S. usual care for patients with TBI (Traumatic Brain Injury), usual care arm activities for younger adults with TBI and their family caregivers will includes usual care discharge planning process and follow up (e.g., verbal and written discharge instructions, with guidance on medications, outpatient therapy, and follow-up appointments).

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,458 Previous Clinical Trials
2,968,903 Total Patients Enrolled
Tolu O Oyesanya, PhD, RnPrincipal InvestigatorDuke University School of Nursing
~333 spots leftby Jan 2027